Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial

风湿性多肌痛 医学 阿巴塔克普 安慰剂 内科学 不利影响 临床终点 巨细胞动脉炎 临床试验 泼尼松龙 随机对照试验 外科 疾病 病理 美罗华 血管炎 替代医学 淋巴瘤
作者
Alain Saraux,Catherine Le Hénaff,Emmanuelle Dernis,Guillermo Carvajal Alegria,Alice Tison,Baptiste Queré,Hélène Petit,Renaud Felten,Sandrine Jousse‐Joulin,Dewi Guellec,Thierry Marhadour,Patrice Kervarrec,Divi Cornec,S. Querellou,Emmanuel Nowak,A. Souki,Valérie Devauchelle‐Pensec
出处
期刊:The Lancet Rheumatology [Elsevier BV]
卷期号:5 (12): e728-e735 被引量:12
标识
DOI:10.1016/s2665-9913(23)00246-1
摘要

Medium-dose glucocorticoids can improve symptoms in nearly all patients with polymyalgia rheumatica. According to its good safety profile, abatacept could be used instead of glucocorticoids in early polymyalgia rheumatica. We aimed to determine whether the efficacy of abatacept is sufficient to justify larger studies in early polymyalgia rheumatica.To evaluate whether abatacept allows low disease activity without glucocorticoids in early polymyalgia rheumatica, we conducted a proof-of-concept, randomised, double-blind, placebo-controlled, parallel-group trial. Participants were recruited from five centres in France (in Brest, Le Mans, Morlaix, Dinan and Saint Malo, and Strasbourg) and were included if they had recent-onset (<6 months) polymyalgia rheumatica with a C-reactive protein (CRP) polymyalgia rheumatica activity score (PMR-AS) of more than 17 without any signs or symptoms of giant cell arteritis (clinical and [18F]fluorodeoxyglucose PET-CT evaluation). Participants were randomly assigned (1:1) to receive weekly subcutaneous abatacept (125 mg) or matching placebo, with glucocorticoid rescue therapy allowed in cases of high disease activity, for 12 weeks, and then glucocorticoid treatment based on disease activity, until week 36. Investigators, patients, outcome assessors, and sponsor personnel were masked to group assignments. The primary endpoint was low disease activity (CRP PMR-AS ≤10) at week 12 without glucocorticoids and without rescue treatment. The study was powered to demonstrate a 60% difference in response rates between groups. Open-ended adverse events were collected at each visit by clinicians and were categorised following system organ class classification after study completion. The ALORS trial is registered with ClinicalTrials.gov, NCT03632187.34 patients (22 women and 12 men) were randomly assigned between Dec 13, 2018, and Oct 21, 2021. All patients who had been randomly assigned were included in the analysis. The primary endpoint was reached by eight (50%) of 16 patients in the abatacept group and four (22%) of 18 patients in the placebo group (relative risk 2·2 [0·9-5·5]); crude p=0·15; adjusted p=0·070). Eight (50%) patients in the abatacept and 15 (83%) in the placebo group had adverse events. Four patients (one [6%] in the abatacept group and three [17%] in the placebo group) had serious adverse events. There were no deaths or new safety concerns.This study suggests that the effect of abatacept alone is not strong enough to justify larger studies in early polymyalgia rheumatica. This is only a first step in deciding whether a larger study should be conducted in early polymyalgia rheumatica and does not exclude a potential effect of abatacept in glucocorticoid-dependent polymyalgia rheumatica.BMS Pharma France.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马甲应助yls采纳,获得10
刚刚
王三完成签到,获得积分10
1秒前
wendinfgmei发布了新的文献求助50
2秒前
Djtc完成签到,获得积分10
2秒前
2秒前
脑洞疼应助背后友蕊采纳,获得10
3秒前
3秒前
4秒前
Owen应助不敢装睡采纳,获得10
4秒前
yubin.cao完成签到,获得积分10
5秒前
Noraaa发布了新的文献求助30
5秒前
huangsan完成签到,获得积分10
5秒前
znn发布了新的文献求助10
5秒前
情怀应助Stern采纳,获得10
5秒前
郭大杠完成签到 ,获得积分10
5秒前
ziming完成签到 ,获得积分10
6秒前
LXD发布了新的文献求助10
6秒前
7秒前
研友_VZG7GZ应助严锦强采纳,获得10
8秒前
Mars_1108发布了新的文献求助10
8秒前
豆子应助稳重向南采纳,获得20
8秒前
平淡惋清完成签到,获得积分10
8秒前
嘟嘟发布了新的文献求助10
8秒前
9秒前
9秒前
田様应助乐正飞风采纳,获得10
9秒前
555557应助小梦采纳,获得10
9秒前
Ae完成签到,获得积分10
10秒前
10秒前
11秒前
11秒前
susu完成签到,获得积分10
11秒前
11秒前
11秒前
11秒前
11秒前
12秒前
冷酷寒安发布了新的文献求助10
13秒前
落林樾发布了新的文献求助10
14秒前
优雅泡芙发布了新的文献求助20
14秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974797
求助须知:如何正确求助?哪些是违规求助? 3519250
关于积分的说明 11197623
捐赠科研通 3255405
什么是DOI,文献DOI怎么找? 1797769
邀请新用户注册赠送积分活动 877156
科研通“疑难数据库(出版商)”最低求助积分说明 806202